動物ワクチンの世界市場:産業分析・機会分析

◆英語タイトル:Veterinary Vaccines Market: Global Industry Analysis and Opportunity Assessment, 2016 – 2026
◆商品コード:FMI609195
◆発行会社(調査会社):Future Market Insights
◆発行日:2016年7月7日
◆ページ数:284
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:医療
◆販売価格オプション(消費税別)
Individual (single user)USD5,000 ⇒換算¥570,000見積依頼/購入/質問フォーム
EnterpriseUSD10,000 ⇒換算¥1,140,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(支払期限と方法は調整可能、振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※レポート購入後、該当レポートに記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はFuture Market Insights社の日本における正規販売代理店です。Future Market Insights社の概要及び新刊レポートはこちらでご確認いただけます。



※本調査レポートでは、動物ワクチンの世界市場について調査・分析し、市場概観、動物ワクチンの世界市場規模、市場規模予測、地域別分析(アメリカ、ヨーロッパ、アジア等)、セグメント別市場分析、競争状況、動物ワクチン市場動向、関連企業分析などを含め、以下の構成でお届けいたします。
【レポートの概要】

This Future Market Insights report examines the ‘Global Veterinary Vaccines Market’ for the period 2016–2026. The primary objective of the report is to offer updates, trends, drivers, restraints, volume and value forecasts and opportunities for manufacturers operating in the global veterinary vaccines market.
Global demand for veterinary vaccines is increasing as a result of improving food security, Improving public health through controlling contagious diseases such as avian influenza, Increasing foodborne and zoonotic diseases and Rising humanization of pets and adoption. Markets in developed economies are witnessing increasing demand for veterinary vaccines due to rising adoption of tried and tested products and the trend is expected to boost the overall demand for veterinary vaccines such as e attenuated live vaccines during the forecast period. To understand and assess the opportunities in this market, the report is categorically split into four sections, namely market analysis by product type, disease application type, animal type, distribution type and region. The report analyses the global veterinary vaccines market in terms of market value (US$ Mn).

The report starts with an overview of the veterinary vaccines market and its usage in various applications globally. In the same section, FMI covers the veterinary vaccines market performance in terms of revenue. This section includes FMI’s analysis of key trends, drivers and restraints from the supply and demand side perspective.

The next section of the report analyses the market based on product type and presents the forecast in terms of value for the next 10 years. Product types covered in the report include:

Attenuated Live Vaccines Market
Conjugate Vaccines Market
Inactivated Vaccines Market
Subunit Vaccines Market
Toxoid Vaccines Market
DNA Vaccines Market
Recombinant Vaccines Market

The next section of the report analyses the market based on disease application type segments and presents the forecast in terms of value for the next ten years. The disease application type segments covered in the report include:

Anaplasmosis
Canine Parvovirus
Foot and Mouth Disease
New Castle Disease
Distemper Disease
Influenza
Porcine Reproductive & Respiratory Syndrome (PRRS)
Others

The next section of the report analyses the market based on animal type segments and presents the forecast in terms of value for the next ten years. The animal type segments covered in the report include:

Companion Animals
Canine
Avine
Feline
Livestock Animals
Aquatic
Bovine
Porcine
Ovine
Poultry
Equine

The next section of the report analyses the market based on distribution channel segments and presents the forecast in terms of value for the next ten years. The distribution channel segments covered in the report include:

Veterinary Clinics
Veterinary Hospitals
Veterinary Research Institutes
Retail Pharmacies

Furthermore, the report analyses the market based on regions and presents the forecast in terms of value for the next ten years. Regions covered in the report include:

North America
Latin America
Western Europe
Eastern Europe
Asia Pacific Excluding Japan
Middle East & Africa (MEA)
Japan

The forecast presented for the market assesses the total revenue generated in the veterinary vaccines market. When developing the forecast, the starting point involves sizing the current market, which forms the basis for the forecast of how the market is anticipated to take shape in the near future. Given the characteristics of market, we triangulated the outcome based on different analysis of the supply side, demand side and GDP growth rate. However, quantifying the market across aforementioned segments and regions is more a matter of quantifying expectations and identifying opportunities rather than rationalising them after the forecast has been completed.

In addition, we have taken into consideration the year-on-year growth to understand the predictability of the market and to identify the right growth opportunities in the global veterinary vaccines market.

As previously highlighted, the global veterinary vaccines market is split into various categories based on region, product type, animal type and application type and distribution channel type. All these segments or categories have been analyzed in terms of Basis Point Share (BPS) to understand the individual segments’ relative contribution to market growth. This detailed level of information is important for identification of various key trends in the global veterinary vaccines market.

Another key feature of this report is the analysis of the veterinary vaccines market by region and product type, animal type and application type and distribution channel type; and the market revenue forecast in terms of absolute dollar opportunity. This is traditionally overlooked while forecasting the market. However, absolute dollar opportunity is critical in assessing the level of opportunity that a provider can look to achieve, as well as to identify potential resources from a sales perspective in the global veterinary vaccines market.

【レポートの目次】

Table Of Content

1. Executive Summary

2. Research Methodology

3. Assumptions & Acronyms Used

4. Definition and Taxonomy

4.1.Market Definition

4.2.Taxonomy

5. Market Dynamics

5.1.Introduction

5.1.1. Drivers

5.1.2. Restraints

5.1.3. Opportunity

5.1.4. Trends

5.1.5. Regulations

6. Overall Market Outlook

6.1.Section Summary

6.2.Global Veterinary Vaccines Market Forecast, 2015-2026

6.3.Introduction

6.3.1. Y-o-Y Growth Projection

6.3.2. Absolute $ Opportunity

7. Global Veterinary Vaccines Market Analysis, By Product Type

7.1. Introduction

7.1.1. Global Veterinary Vaccines Market Overview

7.1.2. Global Veterinary Vaccines Market Value Share, by Product Type

7.1.3. Global Veterinary Vaccines Market Attractiveness by Product Type

7.1.4. Y-o-Y Growth Comparison, By Product Type

7.2. Market Value Forecast, By Product Type

7.2.1. Attenuated Live Vaccines

7.2.1.1. Absolute $ Opportunity

7.2.1.2. Market Value Forecast

7.2.2. Inactivated Vaccines

7.2.2.1. Absolute $ Opportunity

7.2.2.2. Market Value Forecast

7.2.3. Subunit Vaccines

7.2.3.1. Absolute $ Opportunity

7.2.3.2. Market Value Forecast

7.2.4. Toxoid Vaccines

7.2.4.1. Absolute $ Opportunity

7.2.4.2. Market Value Forecast

7.2.5. DNA Vaccines

7.2.5.1. Absolute $ Opportunity

7.2.5.2. Market Value Forecast

7.2.6. Recombinant Vaccines

7.2.6.1. Absolute $ Opportunity

7.2.6.2. Market Value Forecast

7.3. Global Veterinary Vaccines Market Trends, by Product Type

8. Global Veterinary Vaccines Market Analysis, By Diseases

8.1. Introduction

8.1.1. Overview

8.1.2. Global Veterinary Vaccines Market Value Share, by Diseases

8.1.3. Global Veterinary Vaccines Market Attractiveness by Diseases

8.1.4. Y-o-Y Growth Comparison, By Diseases

8.2. Market Value Forecast, By Diseases

8.2.1. Anaplasmosis

8.2.1.1. Absolute $ Opportunity

8.2.1.2. Market Value Forecast

8.2.2. Canine Parvovirus

8.2.2.1. Absolute $ Opportunity

8.2.2.2. Market Value Forecast

8.2.3. Foot & Mouth Disease

8.2.3.1. Absolute $ Opportunity

8.2.3.2. Market Value Forecast

8.2.4. Newcastle Disease

8.2.4.1. Absolute $ Opportunity

8.2.4.2. Market Value Forecast

8.2.5. Distemper Disease

8.2.5.1. Absolute $ Opportunity

8.2.5.2. Market Value Forecast

8.2.6. Influenza Disease

8.2.6.1. Absolute $ Opportunity

8.2.6.2. Market Value Forecast

8.2.7. Porcine Reproductive & Respiratory Syndrome (PRRS) Disease

8.2.7.1. Absolute $ Opportunity

8.2.7.2. Market Value Forecast

8.2.8. Others Disease

8.2.8.1. Absolute $ Opportunity

8.2.8.2. Market Value Forecast

8.3. Global Veterinary Vaccines Market Trends, by Diseases

9. Global Veterinary Vaccines Market Analysis, By Species Type

9.1. Introduction

9.1.1. Overview

9.1.2. Global Veterinary Vaccines Market Value Share, by Species Type

9.1.3. Global Veterinary Vaccines Market Attractiveness By Species Type

9.1.4. Y-o-Y Growth Comparison, By Species Type

9.2. Market Value Forecast, By Species Type

9.2.1. Companion Animal

9.2.1.1. Market Value Forecast

9.2.1.1.1. Canine

9.2.1.1.2. Avian

9.2.1.1.3. Feline

9.2.2. Livestock Animals

9.2.2.1. Market Value Forecast

9.2.2.1.1. Aquatic

9.2.2.1.2. Bovine

9.2.2.1.3. Porcine

9.2.2.1.4. Ovine/Caprine

9.2.2.1.5. Poultry

9.2.3. Equine

9.2.3.1. Absolute $ Opportunity

9.2.3.2. Market Value Forecast

9.3. Global Veterinary Vaccines Market Trends, by Species Type

10. Global Veterinary Vaccines Market Analysis, By Distribution Channel

10.1. Introduction

10.1.1. Global Veterinary Vaccines Market Value Share, by Distribution Channel

10.1.2. Global Veterinary Vaccines Market Attractiveness by Distribution Channel

10.1.3. Y-o-Y Growth Comparison, By Distribution Channel

10.2. Market Value Forecast, By Distribution Channel

10.2.1. Veterinary Clinic Segment

10.2.1.1. Absolute $ Opportunity

10.2.1.2. Market Value Forecast

10.2.2. Veterinary Hospital Segment

10.2.2.1. Absolute $ Opportunity

10.2.2.2. Market Value Forecast

10.2.3. Veterinary Research Institute

10.2.3.1. Absolute $ Opportunity

10.2.3.2. Market Value Forecast

10.2.4. Retail Pharmacies

10.2.4.1. Absolute $ Opportunity

10.2.4.2. Market Value Forecast

10.3. Global Veterinary Vaccines Market Trends, by Distribution Channel

10.4. Global Veterinary Vaccines Market Trends, by Diseases

11. Global Veterinary Vaccines Market Analysis, By Region

11.1. Introduction

11.1.1. Global Veterinary Vaccines Market Value Share, by Region

11.1.2. Global Veterinary Vaccines Market Attractiveness by Region

11.2. Market Value Forecast, By Region

11.2.1. North America

11.2.2. Latin America

11.2.3. Western Europe

11.2.4. Eastern Europe

11.2.5. APEJ

11.2.6. Japan

11.2.7. MEA

12. North America Veterinary Vaccines Market Analysis

12.1. Introduction

12.1.1. North America Veterinary Vaccines Market Value Forecast and Y-o-Y Growth

12.1.2. North America Veterinary Vaccines Market Absolute $ Opportunity

12.1.3. Market Value Forecast

12.1.3.1. By Country

12.1.3.1.1. U.S.

12.1.3.1.2. Canada

12.1.3.2. By Product Type

12.1.3.2.1. Attenuated Live Vaccines

12.1.3.2.2. Conjugate Vaccines

12.1.3.2.3. Inactivated Vaccines

12.1.3.2.4. Subunit Vaccines

12.1.3.2.5. Toxoid Vaccines

12.1.3.2.6. DNA Vaccines

12.1.3.2.7. Recombinant Vaccines

12.1.3.3. By Diseases Type

12.1.3.3.1. Anaplasmosis

12.1.3.3.2. Canine Parvovirus

12.1.3.3.3. Foot & Mouth Disease

12.1.3.3.4. New Castle Disease

12.1.3.3.5. Distemper Disease

12.1.3.3.6. Influenza

12.1.3.3.7. Porcine Reproductive & Respiratory Syndrome (PRRS)

12.1.3.3.8. Others

12.1.3.4. By Distribution Channel

12.1.3.4.1. Veterinary Clinics

12.1.3.4.2. Veterinary Hospitals

12.1.3.4.3. Veterinary Research Institutes

12.1.3.4.4. Retail Pharmacies & Others

12.1.3.5. By Species Type

12.1.3.5.1. Companion Animals

12.1.3.5.1.1. Canine

12.1.3.5.1.2. Avian

12.1.3.5.1.3. Feline

12.1.3.5.2. Livestock Animals

12.1.3.5.2.1. Aquatic

12.1.3.5.2.2. Bovine

12.1.3.5.2.3. Porcine

12.1.3.5.2.4. Ovine/Caprine

12.1.3.5.2.5. Poultry

12.1.3.5.3. Equine

12.1.4. North America Veterinary Vaccines Market Attractiveness

12.1.4.1. By Country

12.1.4.2. By Product Type

12.1.4.3. By Diseases

12.1.4.4. By Distribution Channel

12.1.4.5. By Species Type

12.2. Drivers and Restraints Impact Analysis

13. Latin America Veterinary Vaccines Market Analysis

13.1. Introduction

13.1.1. Latin America Veterinary Vaccines Market Value Forecast and Y-o-Y Growth

13.1.2. Latin America Veterinary Vaccines Market Absolute $ Opportunity

13.1.3. Market Value Forecast

13.1.3.1. By Country

13.1.3.1.1 Argentina

13.1.3.1.2. Brazil

13.1.3.1.3. Mexico

13.1.3.1.4. Rest of Latin America

13.1.3.2. By Product Type

13.1.3.2.1. Attenuated Live Vaccines

13.1.3.2.2. Conjugate Vaccines

13.1.3.2.3. Inactivated Vaccines

13.1.3.2.4. Subunit Vaccines

13.1.3.2.5. Toxoid Vaccines

13.1.3.2.6. DNA Vaccines

13.1.3.2.7. Recombinant Vaccines

13.1.3.3. By Diseases Type

13.1.3.3.1. Anaplasmosis

13.1.3.3.2. Canine Parvovirus

13.1.3.3.3. Foot & Mouth Disease

13.1.3.3.4. New Castle Disease

13.1.3.3.5. Distemper Disease

13.1.3.3.6. Influenza

13.1.3.3.7. Porcine Reproductive & Respiratory Syndrome (PRRS)

13.1.3.3.8. Others

13.1.3.4. By Distribution Channel

13.1.3.4.1. Veterinary Clinics

13.1.3.4.2. Veterinary Hospitals

13.1.3.4.3. Veterinary Research Institutes

13.1.3.4.4. Retail Pharmacies & Others

13.1.3.5. By Species Type

13.1.3.5.1. Companion Animals

13.1.3.5.1.1. Canine

13.1.3.5.1.2. Avian

13.1.3.5.1.3. Feline

13.1.3.5.2. Livestock Animals

13.1.3.5.2.1. Aquatic

13.1.3.5.2.2. Bovine

13.1.3.5.2.3. Porcine

13.1.3.5.2.4. Ovine/Caprine

13.1.3.5.2.5. Poultry

13.1.3.5.3.Equine

13.1.4. Latin America Veterinary Vaccines Market Attractiveness

13.1.4.1. By Country

13.1.4.2. By Product Type

13.1.4.3. By Diseases

13.1.4.4. By Distribution Channel

13.1.4.5. By Species Type

13.2. Drivers and Restraints Impact Analysis

14. Western Europe Veterinary Vaccines Market Analysis

14.1. Introduction

14.1.1. Western Europe Veterinary Vaccines Market Value Forecast and Y-o-Y Growth

14.1.2. Western Europe Veterinary Vaccines Market Absolute $ Opportunity

14.1.3. Market Value Forecast

14.1.3.1. By Country

14.1.3.1.1. Germany

14.1.3.1.2. Italy

14.1.3.1.3. France

14.1.3.1.4. UK

14.1.3.1.5. Spain

14.1.3.1.6. NORDIC Countries

14.1.3.1.7. Benelux

14.1.3.1.8. Rest of Western Europe

14.1.3.2. By Product Type

14.1.3.2.1. Attenuated Live Vaccines

14.1.3.2.2. Conjugate Vaccines

14.1.3.2.3. Inactivated Vaccines

14.1.3.2.4. Subunit Vaccines

14.1.3.2.5. Toxoid Vaccines

14.1.3.2.6. DNA Vaccines

14.1.3.2.7. Recombinant Vaccines

14.1.3.3. By Diseases Type

14.1.3.3.1. Anaplasmosis

14.1.3.3.2. Canine Parvovirus

14.1.3.3.3. Foot & Mouth Disease

14.1.3.3.4. New Castle Disease

14.1.3.3.5. Distemper Disease

14.1.3.3.6. Influenza

14.1.3.3.7. Porcine Reproductive & Respiratory Syndrome (PRRS)

14.1.3.3.8. Others

14.1.3.4. By Distribution Channel

14.1.3.4.1. Veterinary Clinics

14.1.3.4.2. Veterinary Hospitals

14.1.3.4.3. Veterinary Research Institutes

14.1.3.4.4. Retail Pharmacies & Others

14.1.3.5. By Species Type

14.1.3.5.1. Companion Animals

14.1.3.5.1.1. Canine

14.1.3.5.1.2. Avian

14.1.3.5.1.3. Feline

14.1.3.5.2. Livestock Animals

14.1.3.5.2.1. Aquatic

14.1.3.5.2.2. Bovine

14.1.3.5.2.3. Porcine

14.1.3.5.2.4. Ovine/Caprine

14.1.3.5.2.5. Poultry

14.1.3.5.3. Equine

14.1.4. Western Europe Veterinary Vaccines Market Attractiveness

14.1.4.1. By Country

14.1.4.2. By Product Type

14.1.4.3. By Diseases

14.1.4.4. By Distribution Channel

14.1.4.5. By Species Type

14.2. Drivers and Restraints Impact Analysis

15. Eastern Europe Veterinary Vaccines Market Analysis

15.1. Introduction

15.1.1. Eastern Europe Veterinary Vaccines Market Value Forecast and Y-o-Y Growth

15.1.2. Eastern Europe Veterinary Vaccines Market Absolute $ Opportunity

15.1.3. Market Value Forecast

15.1.3.1. By Country

15.1.3.1.1. Russia

15.1.3.1.2. Poland

15.1.3.1.3. Rest of Eastern Europe

15.1.3.2. By Product Type

15.1.3.2.1. Attenuated Live Vaccines

15.1.3.2.2. Conjugate Vaccines

15.1.3.2.3. Inactivated Vaccines

15.1.3.2.4. Subunit Vaccines

15.1.3.2.5. Toxoid Vaccines

15.1.3.2.6. DNA Vaccines

15.1.3.2.7. Recombinant Vaccines

15.1.3.3. By Diseases Type

15.1.3.3.1. Anaplasmosis

15.1.3.3.2. Canine Parvovirus

15.1.3.3.3. Foot & Mouth Disease

15.1.3.3.4. New Castle Disease

15.1.3.3.5. Distemper Disease

15.1.3.3.6. Influenza

15.1.3.3.7. Porcine Reproductive & Respiratory Syndrome (PRRS)

15.1.3.3.8. Others

15.1.3.4. By Distribution Channel

15.1.3.4.1. Veterinary Clinics

15.1.3.4.2. Veterinary Hospitals

15.1.3.4.3. Veterinary Research Institutes

15.1.3.4.4. Retail Pharmacies & Others

15.1.3.5. By Species Type

15.1.3.5.1. Companion Animals

15.1.3.5.1.1. Canine

15.1.3.5.1.2. Avian

15.1.3.5.1.3. Feline

15.1.3.5.2. Livestock Animals

15.1.3.5.2.1. Aquatic

15.1.3.5.2.2. Bovine

15.1.3.5.2.3. Porcine

15.1.3.5.2.4. Ovine/Caprine

15.1.3.5.2.5. Poultry

15.1.3.5.3. Equine

15.1.4. Eastern Europe Veterinary Vaccines Market Attractiveness

15.1.4.1. By Country

15.1.4.2. By Product Type

15.1.4.3. By Diseases

15.1.4.4. By Distribution Channel

15.1.4.5. By Species Type

15.2. Drivers and Restraints Impact Analysis

16. APEJ Veterinary Vaccines Market Analysis

16.1. Introduction

16.1.1. APEJ Veterinary Vaccines Market Value Forecast and Y-o-Y Growth

16.1.2. APEJ Veterinary Vaccines Market Absolute $ Opportunity

16.1.3. Market Value Forecast

16.1.3.1. By Country

16.1.3.1.1. Greater China

16.1.3.1.2. India

16.1.3.1.3. ASEAN

16.1.3.1.4. Australia and NZ

16.1.3.1.5. Rest of APEJ

16.1.3.2. By Product Type

16.1.3.2.1. Attenuated Live Vaccines

16.1.3.2.2. Conjugate Vaccines

16.1.3.2.3. Inactivated Vaccines

16.1.3.2.4. Subunit Vaccines

16.1.3.2.5. Toxoid Vaccines

16.1.3.2.6. DNA Vaccines

16.1.3.2.7. Recombinant Vaccines

16.1.3.3. By Diseases Type

16.1.3.3.1. Anaplasmosis

16.1.3.3.2. Canine Parvovirus

16.1.3.3.3. Foot & Mouth Disease

16.1.3.3.4. New Castle Disease

16.1.3.3.5. Distemper Disease

16.1.3.3.6. Influenza

16.1.3.3.7. Porcine Reproductive & Respiratory Syndrome (PRRS)

16.1.3.3.8. Others

16.1.3.4. By Distribution Channel

16.1.3.4.1. Veterinary Clinics

16.1.3.4.2. Veterinary Hospitals

16.1.3.4.3. Veterinary Research Institutes

16.1.3.4.4. Retail Pharmacies & Others

16.1.3.5. By Species Type

16.1.3.5.1. Companion Animals

16.1.3.5.1.1. Canine

16.1.3.5.1.2. Avian

16.1.3.5.1.3. Feline

16.1.3.5.2. Livestock Animals

16.1.3.5.2.1. Aquatic

16.1.3.5.2.2. Bovine

16.1.3.5.2.3. Porcine

16.1.3.5.2.4. Ovine/Caprine

16.1.3.5.2.5. Poultry

16.1.3.5.3. Equine

16.1.4. APEJ Veterinary Vaccines Market Attractiveness

16.1.4.1. By Country

16.1.4.2. By Product Type

16.1.4.3. By Diseases

16.1.4.4. By Distribution Channel

16.1.4.5. By Species Type

16.2. Drivers and Restraints Impact Analysis

17. JAPAN Veterinary Vaccines Market Analysis

17.1. Introduction

17.1.1. JAPAN Veterinary Vaccines Market Value Forecast and Y-o-Y Growth

17.1.2. JAPAN Veterinary Vaccines Market Absolute $ Opportunity

17.1.3. Market Value Forecast

17.1.3.1. By Product Type

17.1.3.1.1. Attenuated Live Vaccines

17.1.3.1.2. Conjugate Vaccines

17.1.3.1.3. Inactivated Vaccines

17.1.3.1.4. Subunit Vaccines

17.1.3.1.5. Toxoid Vaccines

17.1.3.1.6. DNA Vaccines

17.1.3.1.7. Recombinant Vaccines

17.1.3.2. By Diseases Type

17.1.3.2.1. Anaplasmosis

17.1.3.2.2. Canine Parvovirus

17.1.3.2.3. Foot & Mouth Disease

17.1.3.2.4. New Castle Disease

17.1.3.2.5. Distemper Disease

17.1.3.2.6. Influenza

17.1.3.2.7 Porcine Reproductive & Respiratory Syndrome (PRRS)

17.1.3.2.8. Others

17.1.3.3. By Distribution Channel

17.1.3.3.1. Veterinary Clinics

17.1.3.3.2. Veterinary Hospitals

17.1.3.3.3. Veterinary Research Institutes

17.1.3.3.4. Retail Pharmacies & Others

17.1.3.4. By Species Type

17.1.3.4.1. Companion Animals

17.1.3.4.1.1. Canine

17.1.3.4.1.2. Avian

17.1.3.4.1.3. Feline

17.1.3.4.2. Livestock Animals

17.1.3.4.2.1. Aquatic

17.1.3.4.2.2. Bovine

17.1.3.4.2.3. Porcine

17.1.3.4.2.4. Ovine/Caprine

17.1.3.4.2.5. Poultry

17.1.3.4.3. Equine

17.1.4. JAPAN Veterinary Vaccines Market Attractiveness

17.1.4.1. By Country

17.1.4.2. By Product Type

17.1.4.3. By Diseases

17.1.4.4. By Distribution Channel

17.1.4.5. By Species Type

17.2. Drivers and Restraints Impact Analysis

18. MEA Veterinary Vaccines Market Analysis

18.1. Introduction

18.1.1. MEA Veterinary Vaccines Market Value Forecast and Y-o-Y Growth

18.1.2. MEA Veterinary Vaccines Market Absolute $ Opportunity

18.1.3. Market Value Forecast

18.1.3.1. By Country

18.1.3.1.1. GCC Countries

18.1.3.1.2. South Africa

18.1.3.1.3. Rest of MEA

18.1.3.2. By Product Type

18.1.3.2.1. Attenuated Live Vaccines

18.1.3.2.2. Conjugate Vaccines

18.1.3.2.3. Inactivated Vaccines

18.1.3.2.4. Subunit Vaccines

18.1.3.2.5. Toxoid Vaccines

18.1.3.2.6. DNA Vaccines

18.1.3.2.7. Recombinant Vaccines

18.1.3.3. By Diseases Type

18.1.3.3.1. Anaplasmosis

18.1.3.3.2. Canine Parvovirus

18.1.3.3.3. Foot & Mouth Disease

18.1.3.3.4. New Castle Disease

18.1.3.3.5. Distemper Disease

18.1.3.3.6. Influenza

18.1.3.3.7. Porcine Reproductive & Respiratory Syndrome (PRRS)

18.1.3.3.8. Others

18.1.3.4. By Distribution Channel

18.1.3.4.1. Veterinary Clinics

18.1.3.4.2. Veterinary Hospitals

18.1.3.4.3. Veterinary Research Institutes

18.1.3.4.4. Retail Pharmacies & Others

18.1.3.5. By Species Type

18.1.3.5.1. Companion Animals

18.1.3.5.1.1. Canine

18.1.3.5.1.2. Avian

18.1.3.5.1.3. Feline

18.1.3.5.2. Livestock Animals

18.1.3.5.2.1. Aquatic

18.1.3.5.2.2. Bovine

18.1.3.5.2.3. Porcine

18.1.3.5.2.4. Ovine/Caprine

18.1.3.5.2.5. Poultry

18.1.3.5.3. Equine

18.1.4. MEA Veterinary Vaccines Market Attractiveness

18.1.4.1. By Country

18.1.4.2. By Product Type

18.1.4.3. By Diseases

18.1.4.4. By Distribution Channel

18.1.4.5. By Species Type

18.1.5. Drivers and Restraints Impact Analysis

19. Competition Landscape

19.1. Competition Dashboard

19.2. Company Profiles

19.2.1. Revenue

19.2.2. Product Types/Brand Offerings

19.2.3. Key developments

19.2.4. SWOT Analysis

19.3. Company Highlights

19.3.1. Merial

19.3.2. Zoetis

19.3.3. Elanco

19.3.4. Merck & Co. Inc

19.3.5. Borhinger Inghlem

19.3.6. Bayer Phsrms Ag

19.3.7. Ceva

19.3.8. Verbs



【レポートのキーワード】

動物ワクチン

【免責事項】
※当レポート上の情報/データは調査会社が信頼できると判断した情報源から入手したものに基づき作成しましたが、その正確性・完全性を保証するものではありません。当レポートに記載された情報/データ/見解/仮説などは作成時点又は発行時点における調査会社の判断であり、その後の状況変化に応じて変更される場合があります。当レポート上の情報/データに基づいたお客様の意思決定又は実行による結果について、調査会社/発行会社/販売会社H&Iグローバルリサーチ(株)はその責を負いかねますのでご了承ください。英文資料の紹介ページにおける日本語題名/概要/目次はH&Iグローバルリサーチ(株)が翻訳した内容であり、翻訳の正確性・完全性を保証するものではありません。

★調査レポート[動物ワクチンの世界市場:産業分析・機会分析]についてメールでお問い合わせはこちら


※世界の市場調査資料 総合販売サイトMarketReport.jpはH&Iグローバルリサーチ株式会社が運営しております。海外進出、グローバル事業戦略策定、新規事業機会の発掘、競合他社の動向把握などに必要な情報やインサイトをお客様にご提供しております。H&Iグローバルリサーチ(登録第5864124号)及びH&I(登録第5783645号)はH&Iグローバルリサーチ株式会社の商標です。
※当サイトでは2016年12月05日現在 219,162 件の調査レポートを取り扱っております。当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。

◆H&Iグローバルリサーチのお客様(例)◆